Literature DB >> 29900527

Mortality in schizophrenia: 30-year nationwide follow-up study.

A Tanskanen1,2, J Tiihonen1,2,3, H Taipale1,2,4.   

Abstract

OBJECTIVE: Recent reports suggest that the mortality gap between persons with schizophrenia and the general population is increasing. We investigated the mortality, age at death, and causes of death among persons diagnosed with schizophrenia and the general population in Finland during 1984-2014.
METHODS: All persons with schizophrenia in Finland were identified from hospital discharge register, and compared with the Finnish population aged 16 years and older during 1984-2014, based on data from Statistics Finland. Age at death and standardized mortality ratio (SMR) were calculated for each follow-up year.
RESULTS: Mean age at death increased from 57.6 years in 1984 to 70.1 years in 2014 in persons with schizophrenia, and from 70.9 to 77.5 years in the general population. All-cause SMR remained stable during the follow-up (2.6 in 1984 and 2.7 in 2014). A major change was observed in SMR for suicides which decreased from 11.0 in 1984 to 6.6 in 2014 (-40%). The SMRs for cardiovascular and cancer deaths showed increasing trends.
CONCLUSION: The longevity of persons with schizophrenia is improving at approximately the same rate as the general population but suicide rates have declined substantially. However, there is still a major disparity in mortality compared with general population.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  death; mortality; schizophrenia; suicide

Mesh:

Year:  2018        PMID: 29900527     DOI: 10.1111/acps.12913

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  26 in total

1.  [The CIMH track concept in the treatment of psychotic disorders].

Authors:  Dusan Hirjak; Peter Gass; Michael Deuschle; F Markus Leweke; Andreas Böhringer; Nadine Schenkel; Doris Borgwedel; Marco Heser; Antje Breisacher; Andreas Meyer-Lindenberg
Journal:  Nervenarzt       Date:  2020-03       Impact factor: 1.214

2.  20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20).

Authors:  Heidi Taipale; Antti Tanskanen; Juha Mehtälä; Pia Vattulainen; Christoph U Correll; Jari Tiihonen
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

3.  Performance in Practice: Practice Assessment Tool for the Care of Patients With Schizophrenia.

Authors:  Laura J Fochtmann; Jennifer Medicus; Seung-Hee Hong
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

Review 4.  Schizophrenia Mortality: Barriers to Progress.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2019-09

Review 5.  Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.

Authors:  Irene Bighelli; Alessandro Rodolico; Spyridon Siafis; Myrto T Samara; Wulf-Peter Hansen; Salvatore Salomone; Eugenio Aguglia; Pierfelice Cutrufelli; Ingrid Bauer; Lio Baeckers; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2022-08-30

6.  History of suicide attempts associated with the thinning right superior temporal gyrus among individuals with schizophrenia.

Authors:  Yi Yin; Jinghui Tong; Junchao Huang; Baopeng Tian; Song Chen; Shuping Tan; Zhiren Wang; Fude Yang; Yongsheng Tong; Fengmei Fan; Peter Kochunov; Neda Jahanshad; Chiang-Shan R Li; L Elliot Hong; Yunlong Tan
Journal:  Brain Imaging Behav       Date:  2022-05-12       Impact factor: 3.224

7.  Excess Mortality and Life-Years Lost in People With Schizophrenia and Other Non-affective Psychoses: An 11-Year Population-Based Cohort Study.

Authors:  Nicholas Chak Lam Yung; Corine Sau Man Wong; Joe Kwun Nam Chan; Eric Yu Hai Chen; Wing Chung Chang
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

Review 8.  [Somatic risks in elderly people with severe psychiatric illnesses].

Authors:  Daniel Kopf; Walter Hewer
Journal:  Z Gerontol Geriatr       Date:  2018-10-10       Impact factor: 1.281

9.  Discontinuity of psychiatric care for patients with schizophrenia, relation to previous psychiatric care and practice variation between providers: a retrospective longitudinal cohort study.

Authors:  Arnold P M van der Lee; Adriaan Hoogendoorn; Lieuwe de Haan; Aartjan T F Beekman
Journal:  BMC Psychiatry       Date:  2021-06-29       Impact factor: 3.630

10.  Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.

Authors:  Marco Solmi; Jari Tiihonen; Markku Lähteenvuo; Antti Tanskanen; Christoph U Correll; Heidi Taipale
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.